media – Page 645 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

NICE nods for Amgen’s rare leukaemia drug

Patients with a rare form of leukaemia look set to win routine access to a novel treatment option on the NHS in England and Wales after Amgen’s Blincyto was backed by cost watchdog NICE
- Source: pharmatimes
- 640
- May 3, 2017
cancer Company Insight NHS NICE therapy
The First Communication Meeting with Ddu High Priority Members

Recently, The first face-to-face communication meeting with Ddu high priority members was held by Drugdu.com (Ddu), a global leading pharmaceutical and medical device B2B Online platform. Ddu and the members together discussed the future trend of medical cross-border trade, introduced credit guarantee system, exhibition promotion service and development plan. Ddu also answered questions from members.
- Source: Ddu
- 878
- April 22, 2017
credit verification Exhibitions & Activities member promotion
Ddu Global Promotion Plan — KIMES

The 33rd Korea International Medical& Hospital Equipment Show(KIMES 2017) took place from March 16th to 19th for four days at COEX in Seoul. As an exhibitor, Ddu introduced a special B2B experience to international companies of pharmaceutical and medical device, which won high praise from partners and visitors at home and abroad.
- Source: DDu
- 730
- March 20, 2017
Exhibitions & Activities KIMES promotion

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.